These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23877705)

  • 1. Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity.
    Russell B; Malleret B; Suwanarusk R; Anthony C; Kanlaya S; Lau YL; Woodrow CJ; Nosten F; Renia L
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5170-4. PubMed ID: 23877705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.
    Wirjanata G; Handayuni I; Prayoga P; Apriyanti D; Chalfein F; Sebayang BF; Kho S; Noviyanti R; Kenangalem E; Campo B; Poespoprodjo JR; Price RN; Marfurt J
    Malar J; 2015 Oct; 14():417. PubMed ID: 26498665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates.
    Muhamad P; Chacharoenkul W; Rungsihirunrat K; Ruengweerayut R; Na-Bangchang K
    Asian Pac J Trop Biomed; 2011 Jan; 1(1):49-53. PubMed ID: 23569724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Trianty L; Kenangalem E; Noviyanti R; Campo B; Poespoprodjo JR; Möhrle JJ; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6117-24. PubMed ID: 26195523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.
    Russell BM; Udomsangpetch R; Rieckmann KH; Kotecka BM; Coleman RE; Sattabongkot J
    Antimicrob Agents Chemother; 2003 Jan; 47(1):170-3. PubMed ID: 12499187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug sensitivity testing in Plasmodium vivax.
    Wernsdorfer WH; Tasanor O; Wernsdorfer G
    Wien Klin Wochenschr; 2008; 120(19-20 Suppl 4):30-3. PubMed ID: 19066769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.
    Kaewpongsri S; Sriprawat K; Suwanarusk R; Kyle DE; Lek-Uthai U; Leimanis M; Lwin KM; Phyo AP; Zwang J; Russell B; Nosten F; Renia L
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1300-4. PubMed ID: 21189344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan.
    Khatoon L; Baliraine FN; Bonizzoni M; Malik SA; Yan G
    Am J Trop Med Hyg; 2009 Sep; 81(3):525-8. PubMed ID: 19706926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development.
    Malleret B; Claser C; Ong AS; Suwanarusk R; Sriprawat K; Howland SW; Russell B; Nosten F; Rénia L
    Sci Rep; 2011; 1():118. PubMed ID: 22355635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of drug resistant malaria in Southern Thailand.
    Noisang C; Prosser C; Meyer W; Chemoh W; Ellis J; Sawangjaroen N; Lee R
    Malar J; 2019 Aug; 18(1):275. PubMed ID: 31416468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
    Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Ex Vivo Plasmodium vivax Intraerythrocytic Enrichment and Maturation for Rapid and Sensitive Parasite Growth Assays.
    Rangel GW; Clark MA; Kanjee U; Lim C; Shaw-Saliba K; Menezes MJ; Mascarenhas A; Chery L; Gomes E; Rathod PK; Ferreira MU; Duraisingh MT
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378713
    [No Abstract]   [Full Text] [Related]  

  • 20. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.